CompanyVALNNasdaqSaint-Herblain, I0

Valneva SE

Valneva develops and commercializes prophylactic vaccines against infectious diseases.

SEC EDGAR ClinicalTrials.gov pfizer.com

6-KAug 14Latest SEC filing, period to Dec 31

Aug 14Latest story

August 2026

EMA validates MAA for Pfizer and Valneva's Lyme disease vaccine candidate

Aug 14Regulatory decisionPfizer Valneva SE